Trigger point injections are commonly used in the treatment of myofascial pain. In selected acute or subacute cases, they may provide short-term symptom relief and help a patient participate more effectively in Physical Therapy, stretching, strengthening, and functional restoration. However, chronic repetitive trigger point injections after a minor motor vehicle accident present a different medicolegal question.
The issue is especially difficult when the claimant has a long pre-accident history of musculoskeletal pain or fibromyalgia, receives trigger point injections before the accident, and then continues the same injection pattern afterward without clear documentation of clinical worsening, new objective findings, or sustained functional gains.
In that setting, the physician expert should separate several questions:
- Does the claimant have a diagnosable myofascial pain syndrome?
- Is the pain pattern new or materially changed after the motor vehicle event?
- Were trigger point injections medically reasonable initially?
- Did the injections produce measurable functional improvement?
- Is ongoing repetitive injection therapy supported by evidence?
- Are the injections related to the motor vehicle accident or to a pre-existing chronic pain condition?
- Are the injections restorative treatment or merely transient palliation?
The answer should not be based on generalized skepticism or generalized acceptance. It should be based on the medical record, the examination, functional outcomes, and the literature.
What Are Trigger Points?
Myofascial trigger points are commonly described as hyperirritable spots within skeletal muscle that may be associated with a taut band, local tenderness, referred pain, and sometimes a local twitch response. Trigger point injections involve inserting a needle into the trigger point, sometimes with local anesthetic, saline, corticosteroid, or other injectate. Dry needling uses the needle without medication.
Trigger point diagnosis is clinically based. OpenAnesthesia summarizes that trigger points are identified by palpation and patient feedback, making the diagnosis dependent on subjective and examiner-dependent information. It also notes that the mechanism of trigger points remains uncertain and that systematic reviews have shown neither clear benefit nor clear ineffectiveness of trigger point injections.
That does not mean trigger points are irrelevant. It means the diagnosis is less objective than a fracture, dislocation, nerve compression, or ligament rupture.
Myofascial Pain Versus Fibromyalgia
A key issue in chronic trigger point injection cases is the distinction between regional myofascial pain and fibromyalgia.
Myofascial pain syndrome usually refers to localized or regional muscle pain associated with trigger points. Fibromyalgia is a chronic widespread pain syndrome involving generalized pain sensitivity, fatigue, sleep disturbance, cognitive symptoms, and other systemic features. The two conditions may overlap, but they are not the same.
Medscape notes that myofascial pain syndrome is distinct from fibromyalgia, although they may be concurrent.
This distinction matters for causation. A claimant with longstanding fibromyalgia and widespread musculoskeletal complaints may already have chronic pain vulnerability, diffuse tenderness, and recurrent treatment needs before the accident. A minor motor vehicle event may cause a temporary sprain/strain or flare, but that does not automatically make chronic repetitive trigger point injections accident-related indefinitely.
In a medicolegal report, the physician expert should ask:
- Were trigger point injections being performed before the accident?
- Were the same body regions injected before and after the accident?
- Did injection frequency increase after the event?
- Were new objective findings documented?
- Was there a new regional myofascial pain syndrome distinct from fibromyalgia?
- Did the claimant return to baseline?
- Were there measurable functional gains after injections?
- Did injections replace active care?
Without a documented clinical change, continued injections may represent continuation of pre-existing chronic pain treatment rather than treatment made necessary by the motor vehicle event.
Trigger Point Injections After a Minor Motor Vehicle Accident
A minor motor vehicle accident may cause soft tissue strain. Acute cervical, thoracic, lumbar, or shoulder girdle strain can produce regional muscle pain and tenderness. In the early phase, a limited course of conservative treatment may be medically reasonable. This may include education, activity modification, Physical Therapy, stretching, exercise, nonopioid medication, and sometimes focal injections.
However, a soft tissue strain should generally improve over time. Chronic injection therapy requires evidence that the treatment is doing more than temporarily lowering pain scores.
A reasonable medical-legal framework is:
- Acute phase: short-term regional pain after strain may justify conservative care.
- Subacute phase: treatment should show progressive functional improvement.
- Chronic phase: ongoing passive modalities should require strong evidence of sustained benefit.
- Maintenance phase: indefinite injections require careful scrutiny, especially when function is unchanged.
If the claimant’s clinical status after the accident is essentially the same as before the accident, causation for ongoing injections is weak.
What Does the Literature Say About Trigger Point Injections?
The evidence for trigger point injections is mixed and limited by small studies, heterogeneous methods, variable injectates, inconsistent diagnostic criteria, and difficulty blinding participants.
A 2022 systematic review of trigger point injection therapies for chronic myofascial neck and back pain found that evidence remains limited and that studies vary substantially in technique, comparator groups, and outcome measurement.
A 2023 American Family Physician review was more direct: evidence for medication use in trigger point management is lacking, and many studies have small sample sizes, high risk of bias, difficulty blinding patients, and inconsistent injection techniques. The review also noted that benefits seen with different injection compositions, including normal saline, suggest a strong placebo response.
A systematic review comparing dry needling with trigger point injection for neck pain found only low-quality evidence favoring wet needling for short-term pain reduction and very low-quality evidence for other outcomes.
The practical medicolegal conclusion is not that trigger point injections never help. Rather, the literature does not strongly support chronic repetitive injections as a stand-alone long-term treatment, especially without functional improvement.
Dry Needling Versus Wet Needling
A recurring issue is whether the injectate matters. Some studies suggest that the mechanical effect of the needle may be as important as, or more important than, the medication injected.
A systematic review in Pain Medicine comparing dry needling and trigger point injections for neck pain found low-quality evidence that wet needling may reduce pain more than dry needling in the short term, but no significant effects on other outcomes were supported by very low-quality evidence.
This matters because repeated injection of local anesthetic or corticosteroid should have a clear rationale. If dry needling, saline, or local anesthetic produce similar short-term effects in many contexts, then chronic use of steroid-containing injections becomes harder to justify.
Corticosteroids in Trigger Point Injections
Trigger point injections may include local anesthetic, saline, corticosteroid, or combinations. The use of corticosteroids should be considered carefully.
A 2024 multisociety guideline on corticosteroid use in chronic pain interventions, including trigger point injections, recommends considering local anesthetic alone for trigger point injections and notes potential adverse effects from corticosteroids, including increased blood glucose, decreased bone mineral density, and suppression of the hypothalamic-pituitary axis. The ASRA summary of the same guideline emphasizes that corticosteroid injections can have systemic adverse effects and should not be treated as risk-free.
Therefore, if chronic trigger point injections include corticosteroids, the physician expert should address:
- What injectate was used?
- How frequently were injections performed?
- Were cumulative steroid doses tracked?
- Were risks discussed?
- Was local anesthetic alone considered?
- Were injections in high-risk anatomic regions?
- Were there adverse tissue effects?
- Was ultrasound guidance used when appropriate?
Repeated injections with medication are not equivalent to benign massage.
Risks and Complications
Trigger point injections are generally considered low-risk when properly performed, but they are not risk-free.
Potential complications include:
- Bleeding
- Infection
- Pain flare
- Vasovagal reaction
- Local anesthetic toxicity
- Allergic reaction
- Skin atrophy or depigmentation with steroid
- Muscle injury
- Pneumothorax when performed near the thorax
- Needle injury to nerve, vessel, or deeper structure
The 2024 multisociety guideline states that ultrasound guidance may improve injection accuracy and may be considered for injections near high-risk tissues or deeper trigger points.
In a chronic injection case, risks matter because the cumulative risk increases with repeated procedures. A treatment that is reasonable as a limited intervention may become less reasonable when repeated indefinitely without measurable functional benefit.
Medical Necessity: Pain Relief Is Not Enough
In medicolegal review, a common problem is that post-injection notes document only temporary pain relief:
- “Pain decreased from 8/10 to 4/10.”
- “Patient reports improvement.”
- “Trigger points improved.”
- “Repeat injections recommended.”
That is incomplete. Medical necessity should be tied to function.
The physician expert should look for documentation of:
- Improved range of motion
- Improved strength or endurance
- Increased activity tolerance
- Return to work or improved work capacity
- Reduced use of analgesics
- Reduced healthcare utilization
- Participation in Physical Therapy
- Progression of home exercise
- Improved sleep with increased daytime function
- Improved ability to perform specific activities of daily living
- Longer intervals between treatments
- Durable benefit beyond hours or days
The strongest evidence is not “the patient felt better for 24 hours.” The strongest evidence is that the treatment produced sustained functional gains and reduced dependence on passive care.
If the chart does not change except for the pain score, the medical necessity argument is weak.
Temporary Relief Versus Sustained Functional Gains
Plaintiff or claimant-side arguments may frame temporary relief as medically necessary because it allows the claimant to function, even if relief lasts only a day or two. That argument may be persuasive in some legal settings, especially if the claimant can show specific functional benefit.
However, from a medical necessity standpoint, there is an important distinction between:
- Brief palliative relief, and
- Durable treatment benefit.
A treatment that provides transient comfort may be palliative. It may not be restorative. It may not improve the underlying condition. It may not change impairment. It may not be causally related to a motor vehicle event if the same treatment was needed before the accident.
A medical-legal opinion can acknowledge palliative benefit while rejecting indefinite accident-related necessity:
“The injections may provide transient subjective pain relief. However, the records do not document sustained functional gains, reduced medication use, decreased treatment dependence, or objective improvement. Therefore, ongoing repetitive trigger point injections are not medically necessary as accident-related restorative care.”
Causation: Was the Treatment Made Necessary by the Accident?
Causation is separate from treatment efficacy.
Even if trigger point injections provide temporary relief, the physician expert must determine whether the motor vehicle event caused the need for them. This is especially important when the claimant has fibromyalgia or longstanding musculoskeletal complaints.
Relevant causation questions include:
- Was there a clear new injury from the accident?
- Was the event biomechanically significant?
- Did symptoms begin immediately and regionally?
- Were there objective findings of acute injury?
- Was there a change in diagnosis after the accident?
- Was there a change in treatment frequency or body region?
- Was there a change in functional status?
- Were injections already part of the treatment plan?
- Did the claimant return to pre-accident baseline?
- Are ongoing injections treating fibromyalgia rather than accident-related strain?
A minor non-threatening vehicular event with no documented clinical change is usually weak support for indefinite trigger point injections as accident-related care.
Fibromyalgia and Chronic Injection Treatment
Fibromyalgia is not generally treated with chronic repetitive trigger point injections as primary therapy. Evidence-based fibromyalgia care generally emphasizes education, graded activity, exercise, sleep optimization, cognitive behavioral approaches, and selected medications.
If the claimant’s pain pattern is diffuse, longstanding, and consistent with fibromyalgia, repeated focal injections may not address the underlying condition. More importantly, if the same chronic pain syndrome existed before the accident, ongoing injections may be unrelated to the accident.
A report may state:
“The claimant had a lengthy pre-accident history of widespread musculoskeletal pain diagnosed as fibromyalgia and was receiving trigger point injections before the motor vehicle event. The post-accident records do not document a clinically meaningful change in examination findings, diagnosis, injection pattern, or functional status. The ongoing injections therefore appear to represent continuation of pre-existing chronic pain management rather than treatment made necessary by the motor vehicle event.”
This language is often more defensible than saying simply “trigger point injections do not work.”
Maintenance Injections and the “Whack-a-Mole” Problem
Chronic trigger point injections can become a cycle: pain appears in one muscle region, injections are performed, short-term relief is reported, pain reappears elsewhere or returns, and injections continue indefinitely. This is sometimes described as palliative, recurrent, or maintenance care.
Maintenance care may be appropriate in some chronic conditions, but it requires documentation. The medical record should show:
- Why the treatment is needed
- Why active care alone is insufficient
- What functional goals are achieved
- How long benefit lasts
- Why injection frequency is appropriate
- Whether risks are monitored
- Whether less invasive alternatives were tried
- Whether the treatment reduces medication use or healthcare utilization
- Whether the patient is more functional because of the intervention
Without those elements, chronic injections can become a passive treatment pattern without a clear endpoint.
Practical Report Language for IMEs
A physician expert can use language such as:
“Trigger point injections may be reasonable for short-term management of focal myofascial pain when used as part of an active rehabilitation program. However, the available literature does not strongly support chronic repetitive trigger point injections as a stand-alone long-term treatment, particularly where benefit is limited to transient pain reduction without sustained functional improvement.”
For causation:
“The claimant had a pre-existing history of fibromyalgia and chronic musculoskeletal complaints treated with trigger point injections before the motor vehicle event. The records do not document a material post-accident change in objective findings, diagnosis, functional status, or injection pattern. Therefore, the ongoing injections are more consistent with continuation of pre-existing chronic pain care than treatment necessitated by the motor vehicle event.”
For medical necessity:
“The records do not document sustained functional gains from the injections. There is no consistent evidence of improved range of motion, improved work capacity, decreased medication use, reduced treatment dependence, or durable functional improvement. Continued repetitive injections are therefore not medically necessary as curative or restorative treatment.”
For palliative care:
“The injections may provide temporary subjective relief. Temporary palliative relief, however, is not equivalent to durable medical necessity, particularly when the treatment is requested indefinitely and is not accompanied by measurable functional improvement.”
How This Applies in Medicolegal Reporting
For physician experts, the best approach is to analyze chronic trigger point injections in three separate steps.
- Diagnosis
Determine whether the claimant has focal myofascial pain, fibromyalgia, chronic widespread pain, nonspecific neck/back pain, or another condition. Do not treat every tender muscle as proof of a traumatic trigger point syndrome.
- Causation
Determine whether the motor vehicle event caused a new condition, aggravated a pre-existing condition, or merely preceded continuation of the same chronic pain treatment.
- Medical Necessity
Determine whether ongoing injections are reasonable, necessary, and causally related. This requires more than subjective pain relief. It requires functional benefit.
A strong IME report should avoid unsupported absolutes. The literature does not justify saying trigger point injections are never useful. But it also does not support indefinite repetitive injections after a minor accident when the record lacks objective change and sustained functional improvement.
Practical Implications for Attorneys, Adjusters, and Physician Experts
For attorneys and claims professionals, key questions include:
- Were trigger point injections performed before the accident?
- Were the same areas treated before and after the accident?
- Did the accident cause a documented new injury?
- Was there a meaningful change in clinical findings?
- Did injections produce sustained functional improvement?
- Did the claimant return to work or increase activity?
- Were medications reduced?
- Were injections part of active rehabilitation or a substitute for it?
- What injectate was used?
- Were steroids used repeatedly?
- Were risks and alternatives documented?
- Is the treatment for focal myofascial pain or generalized fibromyalgia?
- Is the requested care restorative, maintenance, or palliative?
For physician experts, the central issue is documentation. If ongoing injections are being justified, the record should show what changed, why the treatment is needed, and what measurable function improved.
Conclusion
Chronic trigger point injections after a minor motor vehicle accident require careful medical-legal analysis. Trigger point injections may have a role in selected patients with focal myofascial pain, particularly as short-term adjuncts to active rehabilitation. However, the evidence does not strongly support indefinite repetitive injections as stand-alone chronic treatment, especially when benefit is limited to transient pain relief.
When a claimant has pre-existing fibromyalgia or longstanding musculoskeletal complaints, the causation analysis becomes even more important. If the post-accident treatment pattern is unchanged and there is no documented clinical deterioration, ongoing injections are more likely continuation of pre-existing chronic pain management than care made necessary by the accident.
For medical-legal reporting, the central principle is clear: temporary pain relief is not the same as sustained functional improvement, and continued treatment must be tied to diagnosis, causation, necessity, and measurable benefit.
References
- Debrosse M, Shergill S, Shah A, Patel K, Gulati A, Rajput K. Trigger point injection therapies for chronic myofascial neck and back pain: a systematic review. Interventional Pain Medicine. 2022;1(4):100076.
- American Family Physician. Trigger Point Management. 2023.
- OpenAnesthesia. Myofascial Pain Syndrome and Trigger Point Injections.
- Navarro-Santana MJ, et al. Dry needling versus trigger point injection for neck pain symptoms associated with myofascial trigger points: a systematic review and meta-analysis. Pain Medicine. 2022;23(3):515-525.
- Martín-Sacristán L, Calvo-Lobo C, Pecos-Martín D, Fernández-Carnero J, Alonso-Pérez JL. Dry needling in active or latent trigger point in patients with neck pain: a randomized clinical trial. Scientific Reports. 2022.
- American Society of Regional Anesthesia and Pain Medicine, American Academy of Pain Medicine, American Society of Interventional Pain Physicians, International Pain and Spine Intervention Society, and North American Spine Society. Use of corticosteroids for adult chronic pain interventions: sympathetic and peripheral nerve blocks, trigger point injections. Regional Anesthesia & Pain Medicine. 2024.
- ASRA Pain Medicine. Use of corticosteroids for adult chronic pain interventions: sympathetic and peripheral nerve blocks, trigger point injections. 2024.